Jump to content
Sclero Forums

Search the Community

Showing results for tags 'sle'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Worldwide
    • Welcome: Guidelines and FAQs
    • Sclero Forums (MAIN)
    • UK Scleroderma
    • News
    • Personal Support

Blogs

  • CFM Babs from Chorley FM
  • barefut impressions
  • My Two Cents...
  • Amanda Thorpe's Blog
  • Joelf's Blog
  • Michael Thorpe's Blog

Found 3 results

  1. Serum level of DNase1l3 in patients with dermatomyositis/polymyositis (DM/PM), systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and its association with disease activity. A significant reduction was found in serum DNase1l3 level in DM/PM and SLE, which may associate with clinic features and disease activity. PubMed, Clin Exp Med, 12/30/2016. (Also see Dermatomyositis and Polymyositis, Research on Systemic Lupus Erythematosus and Causes of Rheumatoid Arthritis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  2. Defining low disease activity (LDA) in systemic lupus erythematosus (SLE). LDA and remission groups had similar short term outcomes and both had better outcomes and prognosis than the high disease activity group. Wiley Online Library, Arthritis Care and Research, 10/01/2016. (Also see What is Systemic Lupus Erythematosus (SLE)?) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  3. Fatigue in systemic lupus erythematosus. Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease often characterized by fatigue, with significant effects on physical functioning and wellbeing. Int J Clin Rheumtol. 2012 Apr 1;7(2):217-227. (Also see: Fatigue and Lupus) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
×